Finished dosage facility of Granules in Hyderabad gets 11 U.S. FDA observations

The U.S. FDA issued a warning letter in February 2025 after inspecting the facility in August–September 2024
More news in Industry
IRDAI upgrades business analytics platform for health covers
IGL net profit plummets 93% on higher input gas cost and consumer price protection
IRDAI declares Nov grievance resolution month; 72% of cases pending for more than a year.